Navigation Links
SciQuest Makes the Inc. 500|5000 List of Fastest-Growing Companies for Fourth Consecutive Year
Date:8/26/2010

of entrepreneurs."

Since assuming the role of CEO in 2001, Weihe has helped turn SciQuest into one of America's fastest-growing private companies. Not only has he been successful in placing SciQuest on the Inc. 500|5000 list, his leadership style has garnered multiple honors including Ernst & Young's Carolinas Entrepreneur of the Year, Triangle Business Journal's "Best Places to Work," American Business Awards' "Turnaround of the Year" and NCTA's "Software Company of the Year."

About SciQuest

SciQuest provides a leading on-demand strategic procurement and supplier enablement solution that integrates customers with their suppliers to improve procurement of indirect goods and services. Our on-demand software enables organizations to realize the benefits of strategic procurement by identifying and establishing contracts with preferred suppliers, driving spend to those contracts and promoting process efficiencies through electronic transactions. Using our managed SciQuest Supplier Network, our customers do business with more than 30,000 unique suppliers and spend billions of dollars annually.

Our current target markets are higher education, life sciences, healthcare and state and local governments. We tailor our solution for each of the vertical markets we serve by offering industry-specific functionality, content and supplier connections. We serve more than 160 customers operating in 16 countries and offer our solution in five languages and 22 currencies.

For more information about SciQuest, please visit www.sciQuest.com or call 888-638-7322 in the U.S. or +44 1794 341182 in Europe.

Trademark information: SciQuest is a registered trademark of SciQuest, Inc. All other trade names are trademarks or registered trademarks of their respective holders.


'/>"/>
SOURCE SciQuest, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. SciQuest Announces Strategic Alliance with Ceiba Solutions
2. SciQuest Announces Strategic Alliance with QIAGEN
3. Continued Demand Makes Monsanto and Agriculture Unique Investment Opportunities, Global Seeds and Traits Lead to Tell Investors
4. New method makes vaccines stable at tropical temperatures
5. Ethanol Blend Reduction in Brazil Makes Sense Provided 90-Day Deadline is Respected, Says Brazilian Sugarcane Industry Association
6. Woman Owned Business President Makes Her Mark at Professional Reprographics
7. U of A led team makes breakthrough demonstration of pH-regulating protein
8. Bioheart Makes Breakthrough in Critical Limb Ischemia Therapy with Stem Cells Obtained from Fat Tissue
9. Promega HaloTag Protein Purification System Makes it Easier to Purify Difficult-to-Express Proteins
10. FDA Advisory Committee Makes Favorable Recommendation for Cervarix, GlaxoSmithKlines Candidate Cervical Cancer Vaccine
11. Biomatrica Makes Several Key Appointments as Part of Continued Growth Plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... MA (PRWEB) July 28, 2014 Immunomic ... two researchers to further develop potential treatments for glioblastoma ... tumor, in combination with their patented vaccine platform, LAMP-vax. ... Duke University, are based on the work of John ... Neurosurgery at The Preston Robert Tisch Brain Tumor Center ...
(Date:7/28/2014)... Appistry, Inc. , a leading ... power of genomics to next-generation medicine, announced today its ... . , Two Appistry staff will be joined ... for Genome Resources, and Mr. Neil Miller, director of ... City. Rounding out the panel are Appistry’s Dr. Richard ...
(Date:7/28/2014)... California (PRWEB) July 28, 2014 The ... 604.40 billion by 2020, according to a new study ... with the rising demand for effective vaccines and drugs ... with unmet medical needs is expected to drive market ... need to enhance agricultural productivity via the use of ...
(Date:7/28/2014)... and COLLEGE STATION, Texas , July ... hotel theatlashotel.com will be a 177-key, 4-star boutique hotel ... Bryan , Texas.  Photo - ... As the first hotel within ATLAS ... 177 rooms, a mixture of standard rooms and suites, a sleek ...
Breaking Biology Technology:String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 3String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 4Appistry Names Industry Experts from the National Center for Genome Resources and Mercy Children's, Kansas City, to Judge Pipeline Challenge Competition 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 3Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 4Texas' Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry 2Texas' Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry 3Texas' Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry 4
... Feb. 28 InterMune, Inc.,(Nasdaq: ITMN ) ... Officer of InterMune, will present at Susquehanna,s Second ... on March 5, 2008,at 2:30 p.m. EST., ... presentation, investors and other,interested parties may log on ...
... ... Feb. 28 Cepheid (Nasdaq:,CPHD) today announced financial results for the fourth quarter and full,year ... Total revenues of $129.5 million, a 48 percent increase from $87.4 ... - Total product sales of $116.5 million, a 41 percent increase from ...
... N.C., Feb. 28 PPD, Inc. (Nasdaq:,PPDI) today ... (NDA) for alogliptin, a highly selective DPP-4 inhibitor ... accepted for filing by the U.S.,Food and Drug ... Under PPD,s agreement with Takeda, the FDA,s ...
Cached Biology Technology:InterMune to Present at the SIGnificant Options in Healthcare Conference 2Cepheid Reports Fourth Quarter and Full Year 2007 Results 2Cepheid Reports Fourth Quarter and Full Year 2007 Results 3Cepheid Reports Fourth Quarter and Full Year 2007 Results 4Cepheid Reports Fourth Quarter and Full Year 2007 Results 5Cepheid Reports Fourth Quarter and Full Year 2007 Results 6Cepheid Reports Fourth Quarter and Full Year 2007 Results 7Cepheid Reports Fourth Quarter and Full Year 2007 Results 8Cepheid Reports Fourth Quarter and Full Year 2007 Results 9Cepheid Reports Fourth Quarter and Full Year 2007 Results 10Cepheid Reports Fourth Quarter and Full Year 2007 Results 11Cepheid Reports Fourth Quarter and Full Year 2007 Results 12Cepheid Reports Fourth Quarter and Full Year 2007 Results 13Cepheid Reports Fourth Quarter and Full Year 2007 Results 14PPD Confirms Takeda's NDA Filing of Alogliptin with U.S. Food and Drug Administration 2
(Date:7/28/2014)... 2014)The Brain & Behavior Research Foundation today announced ... Prizes, recognizing exceptional clinical and basic research by ... Young Investigator Grants. The grants enable early career ... psychosocial research for the prevention, early detection, treatment, ... in four people. , Six young scientistswinners of ...
(Date:7/28/2014)... from fertility problems, many of these due to genetic ... expect such genes, which reduce an individual,s ability to ... Weizmann Institute of Science that recently appeared in ... Not only can it explain the high rates of ... understanding the causes of genetic diseases and their treatment. ...
(Date:7/27/2014)... that nicotine and cotinine, a metabolite of nicotine, can ... in smoke. , The carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone or NNK is ... ends up in the tobacco smoke. Once inhaled, it ... is activated by a variety of enzymes called Cytochrome ... nicotine can partially interfere with the activation of NNK, ...
Breaking Biology News(10 mins):The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 2The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 3The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 4Mutations from Venus, mutations from Mars 2Nicotine found to inhibit DNA-strand break caused by a certain carcinogen in smoke 2
... Pathological gambling can be successfully treated with medications ... researchers at the annual meeting of the American ... outcomes in gamblers treated with medications often used ... pathological gambling disorder will continue their gambling behavior ...
... well-known for his book On the Origin of Species, in ... contributed to many specific fields within biology. As the ... December issue of the American Journal of Botany ... Darwin, Darwin,s contributions to botany, and what scientists have discovered ...
... across the vast expanses of the ocean to attract potential ... decades, and a scientist at Scripps Institution of Oceanography at ... be good news for the population of the endangered marine ... with John Hildebrand of Scripps Oceanography and Sarah Mesnick of ...
Cached Biology News:Pathological gambling may be successfully treated with medications for substance addiction 2Charles Darwin: More than the origin 2Charles Darwin: More than the origin 3The pitch of blue whale songs is declining around the world, scientists discover 2The pitch of blue whale songs is declining around the world, scientists discover 3
... monoclonal [6331] to Salmonella typhimurium The genus ... The genus is composed of Gram-negative bacilli that ... major antigens; the "H" or flagellar antigen (phase ... (part of the LPS moiety) and the "Vi" ...
... sodium pyruvate, 50 mg/L streptomycin sulfate, 100 ... chloride, and magnesium chloride. The use of ... culture is generally attributed to early workers ... developed a solution of inorganic salts designed ...
... is a dramatic breakthrough in accurate, small-volume bulk ... resolution, the micro 1 has unique advantages not ... micro 1 never needs re-calibration as do other ... on an LCD Display , Graphical Row Selection ...
... ( Abpromise for all tested ... Synthetic peptide: VEEESFGPQPISRLE conjugated to KLH, ... 15-29 of Human Rad51 ... Swiss Protein ID: ...
Biology Products: